James C. Fraser, Greenberg Traurig
Greenberg Traurig recently announced that James C. Fraser, a former associate chief counsel for litigation at the FDA, has joined its Litigation and Health Care & FDA practices in Washington, D.C.
Fraser left FDA in August. He has more than 16 years of experience in life sciences litigation and most recently worked in conjunction with the U.S. Department of Justice representing the FDA in civil litigation throughout the United States.
Robert P. Charrow recently returned to Greenberg Traurig as senior chair of the firm’s Health Care & FDA Practice after a stint as HHS general counsel.
“Having worked with Jim for several years, I am certain that his significant ability to successfully litigate complex matters concerning pharmaceuticals, medical devices, and other FDA-regulated products is of tremendous value to our clients,” Charrow said in a news release. “Jim has the rare blend of government and private practice experience that enables him to effectively represent life sciences companies in both FDA issues and consumer litigation matters. I look forward to again working with him, especially as part of a team that includes Health Care & FDA Practice co-chairs David C. Peck and Nancy E. Taylor.”
